Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.380
+0.382 (38.26%)
At close: Apr 2, 2025, 4:00 PM
2.010
+0.630 (45.67%)
After-hours: Apr 2, 2025, 5:17 PM EDT

Aptevo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-24.13-17.418.03-28.46-17.75
Upgrade
Depreciation & Amortization
0.350.570.91.141.31
Upgrade
Loss (Gain) From Sale of Assets
--0.050-
Upgrade
Stock-Based Compensation
1.072.191.81.641.26
Upgrade
Other Operating Activities
-0.01-33.946.642.52
Upgrade
Change in Accounts Receivable
-2.51.16-1.3-2.37
Upgrade
Change in Accounts Payable
-1.020.52-0.39-1.92-0.7
Upgrade
Change in Other Net Operating Assets
-0.06-0.111.370.560.67
Upgrade
Operating Cash Flow
-23.79-11.73-21.02-21.68-29.32
Upgrade
Capital Expenditures
---0.03-0.71-0.09
Upgrade
Other Investing Activities
----28.12
Upgrade
Investing Cash Flow
---0.03-0.7128.03
Upgrade
Long-Term Debt Issued
----24.73
Upgrade
Long-Term Debt Repaid
--3.47-12.27-10.55-22.1
Upgrade
Net Debt Issued (Repaid)
--3.47-12.27-10.552.63
Upgrade
Issuance of Common Stock
15.69.486.9311.4421.26
Upgrade
Repurchase of Common Stock
-0-0.01-0--0.01
Upgrade
Other Financing Activities
-0-2.7225.27-
Upgrade
Financing Cash Flow
15.66-2.6226.1623.87
Upgrade
Net Cash Flow
-8.19-5.73-23.673.7722.59
Upgrade
Free Cash Flow
-23.79-11.73-21.05-22.39-29.41
Upgrade
Free Cash Flow Margin
---676.01%-182.17%-682.43%
Upgrade
Free Cash Flow Per Share
-86.14----
Upgrade
Levered Free Cash Flow
-15.52-11.7-29.322.01-13.29
Upgrade
Unlevered Free Cash Flow
-15.52-11.7-29.322.01-13.29
Upgrade
Change in Net Working Capital
1.57-3.5914.09-13.31-1.43
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q